BANK VONTOBEL/PUT/ELI LILLY & CO/640/0.1/20.09.24

BANK VONTOBEL/PUT/ELI LILLY & CO/640/0.1/20.09.24 Share Price

DE000VM8D221

Real-time Boerse Frankfurt Warrants 05:33:09 18/06/2024 pm IST
0.198 ^EUR	+1.02%

Current month	-65.61%
1 month	-78.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ELI LILLY AND COMPANY

Chart BANK VONTOBEL/PUT/ELI LILLY & CO/640/0.1/20.09.24

Latest news about ELI LILLY AND COMPANY

Health Care Flat as Traders Wait More Obesity-Drug Updates - Health Care Roundup	18/06	DJ
Health Care Slips as Gilead Rallies on Weight-Loss Plans - Health Care Roundup	15/06	DJ
Investors need more time to assess Fed comments	14/06
Musk wins pay approval but still faces Tesla's floundering stock and rich valuation	14/06	RE

More news

Quotes 5-day view

Date	Price	Change
18/24/18	0.198	+1.02%
17/24/17	0.196	-6.67%
14/24/14	0.21	-5.41%
13/24/13	0.222	-17.78%
12/24/12	0.27	+3.85%

Real-time Boerse Frankfurt Warrants

Last update June 18, 2024 at 05:33 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	ELI LILLY AND COMPANY
Issuer	Vontobel
WKN	VM8D22
ISIN	DE000VM8D221
Date issued	11/01/2024
Strike	640 $
Maturity	20/09/2024 (94 Days)
Parity	10 : 1
Emission price	5.6 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	6.12 €
Lowest since issue	0.196 €
Spread	0.017 €
Spread %	7.91%

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Sector

More about the company